NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

呼吸疾病檢驗的全球市場:產品,終端用戶別的預測(到2025年)- COVID-19累積的影響

Respiratory Disease Testing Market Research Report by Product, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1006159
出版日期 內容資訊 英文 191 Pages
商品交期: 最快1-2個工作天內
價格
呼吸疾病檢驗的全球市場:產品,終端用戶別的預測(到2025年)- COVID-19累積的影響 Respiratory Disease Testing Market Research Report by Product, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 191 Pages
簡介

全球呼吸疾病檢驗的市場規模預測將從2020年的 36 億 1,787 從萬美元,擴大到2025年末的 42 億 7,788 萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察,分析,與預測。

本報告提供全球呼吸疾病檢驗市場的相關調查,提供市場機會和課題,成長及阻礙因素,COVID-19累積的影響,產品·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查對象年
  • 貨幣和價格
  • 語言
  • 限制事項
  • 相關利益者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查器具
    • 收集: 資料來源
    • 分析: 資料解釋
    • 制定: 資料檢驗
    • 發行:調查報告書
    • 反復: 報告的更新
  • 調查實施
    • 開始:調查流程
    • 計劃:調查計劃的制定
    • 實行:調查的實施
    • 檢驗: 發現與分析
    • 發行:調查報告書
  • 調查成果

第3章 摘要整理

  • 市場展望
  • 各終端用戶市場展望
  • 各產品市場展望
  • 各地區市場的展望
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19的累積性的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 各產品市場

  • 血氣檢驗
  • 影像檢查
  • 呼吸檢測

第7章 各終端用戶市場

  • 臨床檢驗室
  • 醫院

第8章 南北美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區市場

  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東·非洲市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV 定位 矩陣
    • 象限
    • 事業策略
    • 產品滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第12章 企業簡介

  • Abbott Laboratories
  • Alere Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerieux
  • CareFusion Corporation
  • Carestream Medical
  • Cosmed
  • Fisher & Paykel Healthcare Limited
  • Fujifilm Holdings
  • GE Healthcare
  • Hitachi Medical Corporation
  • Koninklijke Philips N.V
  • Medtronic Plc
  • MGC Diagnostics Corporation
  • ResMed
  • Sdi Diagnostics
  • Seegene Inc.
  • SELUTEC GmbH
  • Shimadzu Corporation
  • Siemens Healthcare
  • Thermo Fisher Scientific Inc.
  • Toshiba Medical Systems Corporation

第13章 附錄

  • 討論指南
  • 許可證和價格
  • 聯絡處詳細內容

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-035AB9C0DAAE

The Global Respiratory Disease Testing Market size was estimated at USD 3,617.87 Million in 2020 and expected to reach USD 3,759.27 Million in 2021, at a Compound Annual Growth Rate (CAGR) 4.24% to reach USD 4,643.28 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Respiratory Disease Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Respiratory Disease Testing Market was studied across Blood Gas Test, Imaging Tests, and Respiratory Measurement.

Based on End-User, the Respiratory Disease Testing Market was studied across Clinical Laboratories and Hospitals.

Based on Geography, the Respiratory Disease Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Respiratory Disease Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Respiratory Disease Testing Market, including Abbott Laboratories, Alere Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerieux, CareFusion Corporation, Carestream Medical, Cosmed, Fisher & Paykel Healthcare Limited, Fujifilm Holdings, GE Healthcare, Hitachi Medical Corporation, Koninklijke Philips N.V, Medtronic Plc, MGC Diagnostics Corporation, ResMed, Sdi Diagnostics, Seegene Inc., SELUTEC GmbH, Shimadzu Corporation, Siemens Healthcare, Thermo Fisher Scientific Inc., and Toshiba Medical Systems Corporation.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Respiratory Disease Testing Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Respiratory Disease Testing Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Respiratory Disease Testing Market?
  • 4. What is the competitive strategic window for opportunities in the Global Respiratory Disease Testing Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Respiratory Disease Testing Market?
  • 6. What is the market share of the leading vendors in the Global Respiratory Disease Testing Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Respiratory Disease Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. End-User Outlook
  • 3.4. Product Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of respiratory diseases
      • 5.1.1.2. Adoption of unhealthy lifestyle and habits such as tobacco smoking
      • 5.1.1.3. Constantly rising air pollution levels
      • 5.1.1.4. Major adoption of imaging technology for diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternatives systems and devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising preferences for remote or home care testing devices
      • 5.1.3.2. R&D and technology advancements in testing methods for effective, efficient, and faster results
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of supportive reimbursement policies
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Respiratory Disease Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Blood Gas Test
  • 6.3. Imaging Tests
  • 6.4. Respiratory Measurement

7. Respiratory Disease Testing Market, by End-User

  • 7.1. Introduction
  • 7.2. Clinical Laboratories
  • 7.3. Hospitals

8. Americas Respiratory Disease Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Respiratory Disease Testing Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Respiratory Disease Testing Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Alere Inc.
  • 12.3. Becton, Dickinson and Company
  • 12.4. Bio-Rad Laboratories, Inc.
  • 12.5. Biomerieux
  • 12.6. CareFusion Corporation
  • 12.7. Carestream Medical
  • 12.8. Cosmed
  • 12.9. Fisher & Paykel Healthcare Limited
  • 12.10. Fujifilm Holdings
  • 12.11. GE Healthcare
  • 12.12. Hitachi Medical Corporation
  • 12.13. Koninklijke Philips N.V
  • 12.14. Medtronic Plc
  • 12.15. MGC Diagnostics Corporation
  • 12.16. ResMed
  • 12.17. Sdi Diagnostics
  • 12.18. Seegene Inc.
  • 12.19. SELUTEC GmbH
  • 12.20. Shimadzu Corporation
  • 12.21. Siemens Healthcare
  • 12.22. Thermo Fisher Scientific Inc.
  • 12.23. Toshiba Medical Systems Corporation

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL RESPIRATORY DISEASE TESTING MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL RESPIRATORY DISEASE TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 10. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 17. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2026
  • FIGURE 19. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 24. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 26. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 27. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 28. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 29. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 30. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 31. CALIFORNIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 32. FLORIDA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. ILLINOIS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. NEW YORK RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. OHIO RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. PENNSYLVANIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. TEXAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 39. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 41. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 50. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 52. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. GLOBAL RESPIRATORY DISEASE TESTING MARKET: FPNV POSITIONING MATRIX
  • FIGURE 64. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 65. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL RESPIRATORY DISEASE TESTING MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CALIFORNIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. CALIFORNIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. FLORIDA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. FLORIDA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. ILLINOIS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. ILLINOIS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. NEW YORK RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. NEW YORK RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. OHIO RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. OHIO RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. PENNSYLVANIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. PENNSYLVANIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. TEXAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. TEXAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SCORES
  • TABLE 83. GLOBAL RESPIRATORY DISEASE TESTING MARKET: BUSINESS STRATEGY
  • TABLE 84. GLOBAL RESPIRATORY DISEASE TESTING MARKET: PRODUCT SATISFACTION
  • TABLE 85. GLOBAL RESPIRATORY DISEASE TESTING MARKET: RANKING
  • TABLE 86. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 87. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SHARE, BY COMPANY, 2020
  • TABLE 88. GLOBAL RESPIRATORY DISEASE TESTING MARKET: MERGER & ACQUISITION
  • TABLE 89. GLOBAL RESPIRATORY DISEASE TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 90. GLOBAL RESPIRATORY DISEASE TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 91. GLOBAL RESPIRATORY DISEASE TESTING MARKET: INVESTMENT & FUNDING
  • TABLE 92. GLOBAL RESPIRATORY DISEASE TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 93. GLOBAL RESPIRATORY DISEASE TESTING MARKET: LICENSE & PRICING
  • TABLE 94. GLOBAL RESPIRATORY DISEASE TESTING MARKET: CONTACT DETAILS